Asymmetric Unit (15, 15)
No. | Name | Evidence | Residues | Description |
01 | AC1 | SOFTWARE | CYS A:355 , CYS A:360 , HIS A:373 , HIS A:377 | binding site for residue ZN A 501 |
02 | AC2 | SOFTWARE | CYS A:385 , CYS A:388 , HIS A:401 , HIS A:405 | binding site for residue ZN A 502 |
03 | AC3 | SOFTWARE | CYS A:413 , CYS A:418 , HIS A:431 , HIS A:435 | binding site for residue ZN A 503 |
04 | AC4 | SOFTWARE | CYS A:355 , CYS A:360 , HOH A:627 , HOH A:633 | binding site for residue CA A 504 |
05 | AC5 | SOFTWARE | ARG A:390 , HIS A:401 , DG B:4 | binding site for residue EDO A 505 |
06 | AC6 | SOFTWARE | CYS D:355 , CYS D:360 , HIS D:373 , HIS D:377 | binding site for residue ZN D 501 |
07 | AC7 | SOFTWARE | CYS D:385 , CYS D:388 , HIS D:401 , HIS D:405 | binding site for residue ZN D 502 |
08 | AC8 | SOFTWARE | CYS D:413 , CYS D:418 , HIS D:431 , HIS D:435 | binding site for residue ZN D 503 |
09 | AC9 | SOFTWARE | HOH A:646 , CYS D:355 , CYS D:360 , HOH D:620 , HOH D:626 | binding site for residue CA D 504 |
10 | AD1 | SOFTWARE | ARG D:372 , SER D:393 , ARG D:394 , DG E:6 , HOH E:104 | binding site for residue EDO D 505 |
11 | AD2 | SOFTWARE | DC F:6 | binding site for residue NA F 101 |
12 | AD3 | SOFTWARE | LYS D:351 , PHE D:364 , HIS D:369 , ARG D:372 , DG E:7 , DG E:10 , HOH E:112 , HOH E:116 , HOH E:121 , DG F:4 , DC F:5 , DC F:6 | binding site for Di-nucleotide DG E 8 and 5FC E 9 |
13 | AD4 | SOFTWARE | LYS D:351 , ARG D:366 , HIS D:369 , ARG D:372 , DG E:8 , DT E:11 , HOH E:111 , HOH E:112 , DA F:2 , 5CM F:3 , DG F:4 | binding site for Di-nucleotide 5FC E 9 and DG E 10 |
14 | AD5 | SOFTWARE | ARG D:366 , ASP D:368 , DA E:1 , DG E:10 , DT E:11 , DT F:1 , DG F:4 , HOH F:206 , HOH F:207 , HOH F:209 | binding site for Di-nucleotide DA F 2 and 5CM F 3 |
15 | AD6 | SOFTWARE | ASP D:368 , ARG D:372 , LYS D:399 , HOH D:616 , DG E:8 , 5FC E:9 , DG E:10 , DA F:2 , DC F:5 | binding site for Di-nucleotide 5CM F 3 and DG F 4 |
|